Law360, New York ( February 25, 2014, 12:47 PM EST) -- For decades, Congress and the U.S. Supreme Court had assured patentees in the biotechnology space that "anything under the sun that is made by man" could be patent-eligible.[1] This understanding was upended in 2012, when the Supreme Court revisited the question of patentability under 35 U.S.C. § 101 in Mayo Collaborative Services v. Prometheus Laboratories Inc.[2]...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.